Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2005 (Vol. 25, No. 18)

Profiles in Science

  • Well written
  • Should include a larger number of scientists
Longtime readers of this page know I have a strong interest in history. I have covered numerous historical sites, so I was surprised not to have previously noted this interesting one from the National Library of Medicine. Titled Profiles in Science, the site "celebrates twentieth-century leaders in biomedical research and public health" by making collections of prominent scientists and physicians available for general access. The set includes giants like Linus Pauling, Francis Crick, Barbara McClintock, and Albert Szent-Gyorgi, among others. At least one contemporary medical personality, Dr. C. Everett Koop, is also included. The collections are excellent resources of general information and provide links to more extensive sites, devoted solely to some of these people. A great place for science history buffs.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »